Switching renal transplant recipients to belatacept therapy: results of a real-life gradual conversion protocol
{{output}}
Conversion to belatacept immunosuppression is a therapeutic option for renal-transplant recipients with calcineurin inhibitors (CNI) toxicity, but it associates with high risk of acute rejection. Gradual conversion and serial immune monitoring with urinary che... ...
